质量分析

特征图谱、一测多评与模式识别相结合的茵陈【茵陈蒿(绵茵陈)】配方颗粒质量评价分析*

展开
  • 1.山东宏济堂制药集团股份有限公司 山东省中医药治疗呼吸系统疾病技术创新中心,济南250103;
    2.山东省食品药品检验研究院,济南250101
第一作者 Tel:18851447267;E-mail:cgyxfys@163.com
**Tel:15951768938;E-mail:cpummm@163.com

收稿日期: 2023-08-14

  网络出版日期: 2024-06-20

基金资助

*山东省重点研发计划重大科技创新工程项目(2021CXGC010511);泉城“5150”引才倍增计划项目(2021年)

Quality evaluation of Artemisiae Scopariae Herba [Artemisia capillaris Thunb. (Mianyinchen)] dispensing granules by combination of characteristic chromatogram, quantitative analysis of multi-components by single marker and chemical pattern recognition analysis*

Expand
  • 1. Shandong Hongjitang Pharmaceutical Group Co., Ltd., Shandong Province Technical Innovation Center of Traditional Chinese Medicine Treatment of Respiratory Diseases, Jinan 250103, China;
    2. Shandong Provincial Institute for Food and Drug Control, Jinan 250101, China

Received date: 2023-08-14

  Online published: 2024-06-20

摘要

目的: 建立特征图谱、一测多评和化学模式识别分析相结合的茵陈【茵陈蒿(绵茵陈)】配方颗粒质量评价方法。方法: 利用制备的15批茵陈【茵陈蒿(绵茵陈)】标准汤剂和3批配方颗粒建立了HPLC特征图谱,并对其中6个主要成分建立一测多评法进行含量测定。采用AcclaimTM RSLC 120 C18(100 mm×2.1 mm,2.2 μm)色谱柱,以乙腈-0.05%磷酸水溶液为流动相,梯度洗脱,流速0.4 mL·min-1,检测波长327 nm。进行相似度评价、聚类分析(HCA)及主成分分析(PCA)。计算指标成分从饮片到标准汤剂及配方颗粒的转移率。结果: 15批茵陈【茵陈蒿(绵茵陈)】标准汤剂和3批配方颗粒特征图谱相似度>0.85,共确定了8个共有峰。HCA、PCA的分析结果显示茵陈【茵陈蒿(绵茵陈)】配方颗粒与标准汤剂成分一致性较好。15批茵陈【茵陈蒿(绵茵陈)】标准汤剂中新绿原酸、绿原酸、隐绿原酸、异绿原酸B、异绿原酸A、异绿原酸C含量分别为1.87~5.23、7.44~15.26、2.85~8.18、3.05~6.14、0.99~3.93、3.23~10.38 mg·g-1,饮片到标准汤剂的转移率分别为23.85%~37.28%、19.57%~31.93%、28.15%~45.88%、22.34%~36.59%、16.64%~28.36%、21.81%~39.19%。茵陈【茵陈蒿(绵茵陈)】配方颗粒指标成分含量、转移率与标准汤剂接近。结论: 所建立所建指纹图谱及一测多评分析方法可用于茵陈【茵陈蒿(绵茵陈)】配方颗粒的质量评价及工艺研究。

本文引用格式

曹桂云, 庄雪松, 宁波, 刘羽康, 王全军, 刘兴村, 林永强, 崔伟亮, 张风超, 刘子夜, 孟兆青 . 特征图谱、一测多评与模式识别相结合的茵陈【茵陈蒿(绵茵陈)】配方颗粒质量评价分析*[J]. 药物分析杂志, 2024 , 44(4) : 689 -704 . DOI: 10.16155/j.0254-1793.2024.04.16

Abstract

Objective: To establish a method for quality evaluation of Artemisiae Scopariae Herba [Artemisia capillaris Thunb. (Mianyinchen)] dispensing granules by combining characteristic chromatogram, quantitative analysis of multi-components by single marker (QAMS) and chemical pattern recognition analysis. Methods: The high performance liquid chromatography (HPLC) characteristic chromatogram was established by 15 batches of Artemisiae Scopariae Herba [Artemisia capillaris Thunb. (Mianyinchen)] standard decoctions and 3 batches of dispensing granules. The contents of 6 components were determined by QAMS. The chromatographic separation was achieved on a AcclaimTM RSLC 120 C18 column (100 mm×2.1 mm,2.2 μm), with the mobile phase comprising of acetonitrile-0.05% phosphoric acid flowing at 0.4 mL·min-1 in a gradient elution manner. And the detection wavelength was set at 327 nm. The similarity evaluation system of fingerprint of traditional Chinese medicine was used to determine the common peak for similarity evaluation. Hierarchical cluster analysis (HCA) and principal component analysis (PCA) were applied for chemical pattern recognition. The transfer rates of the 6 components from decoction pieces to standard decoctions and dispensing granules were calculated. Results: The similarities of characteristic chromatograms of 15 batches of Artemisiae Scopariae Herba [Artemisia capillaris Thunb. (Mianyinchen)] standard decoctions and 3 batches of dispensing granules were all above 0.85. And 8 common characteristic peaks were identified. The results of HCA and PCA indicated the similarity of ingredients in formula granules to those in standard decoctions. The contents of neochlorogenic acid, chlorogenic acid, cryptochlorogenic, isochlorogenic acid B, isochlorogenic acid A, isochlorogenic acid C in standard decoctions were 1.87-5.23, 7.44-15.26, 2.85-8.18, 3.05-6.14, 0.99-3.93 and 3.23-10.38 mg·g-1 and the transfer rates of these components from decoction pieces to standard decoction were 23.85%-37.28%, 19.57%-31.93%, 28.15%-45.88%, 22.34%-36.59%, 16.64%-28.36% and 21.81%-39.19%, respectively. The contents and transfer rates of these 6 compounds in dispensing granules were close to that of standard decoctions. Conclusion: The characteristic chromatogram and QAMS method established can be used for quality control and process research of Artemisiae Scopariae Herba [Artemisia capillaris Thunb. (Mianyinchen)] dispensing granules.

参考文献

[1] 中华人民共和国药典2020年版. 一部[S]. 2020: 250
ChP 2020. Vol Ⅰ[S]. 2020: 250
[2] 黄丽平, 许远航, 邓敏贞, 等. 茵陈的化学成分、药理作用机制与临床应用研究进展[J].天然产物研究与开发, 2021, 33(4):676
HUANG LP, XU YH, DENG MZ, et al. Research progress on chemical constituents, pharmacological mechanism and clinical application of Artemisiae Scopariae Herba[J]. Nat Prod Res Dev, 2021, 33(4):676
[3] 刘玉萍, 邱小玉, 刘烨, 等. 茵陈的药理作用研究进展[J]. 中草药, 2019, 50(9):2235
LIU YP, QIU XY, LIU Y, et al. Research progress on pharmacological effect of Artemisiae Scopariae Herba[J]. Chin Tradit Herb Drugs, 2019, 50(9):2235
[4] CAI Y, ZHENG Q, SUN R, et al. Recent progress in the study of Artemisiae Scopariae Herba (Yin Chen), a promising medicinal herb for liver diseases[J]. Biomed Pharmacother, 2020, 130: 110513
[5] 国家药品监督管理局. 国家药监局关于发布《中药配方颗粒质量控制与标准制定技术要求》的通告(2021年第16号)[EB/OL]. [2021-02-10]. http://www.gov.cn/zhengce/zhengceku/2021-02/11/content_5586817.htm.
National Medical Products Administration. NMPA Announcement on Technical Requirements for Quality Control and Standard Formulation of Traditional Chinese Medicine Formula Granules[EB/OL]. [2021-02-10]. http://www.gov.cn/zhengce/zhengceku/2021-02/11/content_5586817.htm.
[6] 田芳, 阮群珈, 石星, 等. 茵陈饮片与茵陈标准汤剂的质量比较研究[J]. 中国现代中药, 2020, 22(1):98
TIAN F, RUAN QJ, SHI X, et al. Comparative study on the quality of Artemisia capillaris and its standard decoction [J]. Mod Chin Med, 2020, 22(1):98
[7] 李雅静, 孙博, 朱广伟, 等. 基于传统煎药工艺的茵陈蒿饮片标准汤剂制备及质量标准研究[J]. 中华中医药学刊, 2019, 37(6):1412
LI YJ, SUN B, ZHU GW, et al. Study on preparation and quality evaluation of standard decoction of Artemisia capillaris based on traditional decocting process[J]. Chin Arch Tradit Chin Med, 2019, 37(6):1412
[8] 张影, 许华容, 李军山, 等. 基于一测多评法的茵陈标准汤剂中8种成分同时定量研究[J]. 药学学报, 2019, 54(9):1661
ZHANG Y, XU HR, LI JS, et al. Simultaneous quantitative analyses of eight components in Artemisia capillaris Thunb standard decoction based on a quantitative method of multi-components with a single-marker[J]. Acta Pharm Sin, 2019, 54(9):1661
[9] 倪丽丽. 基于标准汤剂的茵陈蒿汤组方药味配方颗粒质量评价研究[D]. 南京: 南京中医药大学, 2020
NI LL. Quality Evaluation of Dispensing Granules Made of Yinchenhao Tang Based on Standard Decoction[D]. Nanjing: Nanjing University of Chinese Medicine, 2020
[10] 位翠杰, 陈芳, 丁青, 等. 基于UPLC指纹图谱和多成分定量的茵陈配方颗粒质量控制研究[J]. 中国中医药信息杂志, 2021, 28(10):99
WEI CJ, CHEN F, DING Q, et al. Quality control of Artemisiae Scopariae Herba dispensing granules cased on UPLC fingerprints and multi-component content determination[J]. Chin J Inf Tradit Chin Med, 2021, 28(10):99
[11] 浦香兰, 张云天. 茵陈配方颗粒HPLC特征图谱研究[J]. 中国现代应用药学, 2014, 31(10):1195
PU XL, ZHANG YT. HPLC characteristic chromatograms of formula granule of Artemisiae Scopariae Herba[J]. Chin J Mod Appl Pharm, 2014, 31(10):1195
[12] 宗时宇, 刘洋, 张红, 等. 不同基原与产地的细辛质量评价及肝毒性化学成分定量分析[J]. 时珍国医国药, 2021, 32(6):1351
ZONG SY, LIU Y, ZHANG H, et al. Quality evaluation and quantitative analysis of hepatotoxic components of Asari Radixet Rhizoma from different habitats[J]. Lishizhen Med Mater Med Res, 2021, 32(6):1351
[13] 于梦婷, 童黄锦, 毛春芹, 等. 基于色泽量化与主要成分含量的不同基原莪术饮片质量识别研究[J]. 中国中药杂志, 2021, 46(6):1393
YU MT, TONG HJ, MAO CQ, et al. Study on quality identification of Curcumae Rhizoma from different habitats based on quantitative analysis of appearance color and content of main components[J]. China J Chin Mater Med, 2021, 46(6):1393
[14] 李振雨, 陈万发, 王利伟, 等. 不同基原厚朴UPLC指纹图谱及化学模式识别研究[J]. 中草药, 2022, 53(1):244
LI ZY, CHEN WF, WANG LW, et al. UPLC fingerprint and chemical pattern recognition of Magnoliae Officinalis Cortex from different habitats[J]. Chin Tradit Herb Drugs, 2022, 53(1):244
[15] 韩晋, 金城, 刘太华, 等. 不同采收期和不同部位茵陈药材滨蒿内酯的含量测定与资源利用建议[J]. 解放军药学学报, 2005, 21(2):155
HAN J, JIN C, LIU TH, et al. Determination of scoparone in different parts and harvest time of Scoparia and rational utilization of its resources[J]. Pharm J Chin PLA, 2005, 21(2):155
[16] YU MH, HUNG TW, WANG CC, et al. Neochlorogenic acid attenuates hepatic lipid accumulation and inflammation via regulating miR-34a in vitro[J]. Int J Mol Sci, 2021, 22(23):13163
[17] LU H, TIAN Z, CUI Y, et al. Chlorogenic acid: a comprehensive review of the dietary sources, processing effects, bioavailability, beneficial properties, mechanisms of action, and future directions[J]. Compr Rev Food Sci Food Saf, 2020, 19(6):3130
[18] MA X, OKYERE SK, HU L, et al. Anti-Inflammatory activity and mechanism of cryptochlorogenic acid from Aageratina adenophora[J]. Nutrients, 2022, 14(3):439
[19] LIU X, HUANG K, NIU Z, et al. Protective effect of isochlorogenic acid B on liver fibrosis in non-alcoholic steatohepatitis of mice[J]. Basic Clin Pharmacol Toxicol, 2019, 124(2):144
[20] QI H, SHI Y, WU H, et al. Inhibition of temperature-sensitive TRPV3 channel by two natural isochlorogenic acid isomers for alleviation of dermatitis and chronic pruritus[J]. Acta Pharm Sin B, 2022, 12(2):723
[21] ZHENG L, LIN G, LI R, et al. Isochlorogenic acid C alleviates high-fat diet-induced hyperlipemia by promoting cholesterol reverse transport[J]. Front Pharmacol, 2022, 13: 881078
文章导航

/